Quest Magazine

BioMarin, Sarepta Announce Dates for FDA Advisory Committee Meetings

Five Questions with FSHD Researcher Antoine de Morrée

President Obama Signs Ensuring Access to Clinical Trials Act (S.139/HR 209) Into Law

Enrollment in Diaphragm Pacing Systems for People with ALS Halted

Sarepta Reports Data from Phase 2 Trial of Eteplirsen for Treatment of DMD

Sarepta Therapeutics Announces USPTO Decision in Patent Interference Case with BioMarin Pharmaceutical

BioMarin Receives Favorable Ruling in the Use of Exon 51 Antisense Oligonucleotides Patent Interference

Five Questions with Researcher Criss Hartzell

Five Questions with CMT Researchers Robert Burgess and Scott Harper

MDA Statement: Fire Fighter and MDA Volunteer Dennis Rodeman Victim of Hit-and-Run